The world has been affected by COVID-19 coronavirus. At the time of this study, the number of infected people in the United States is the highest globally (7.9 million infections). Within the infected population, patients diagnosed with acute respiratory distress syndrome (ARDS) are in more life-threatening circumstances, resulting in severe respiratory system failure. Various studies have investigated the infections to COVID-19 and ARDS by monitoring laboratory metrics and symptoms. Unfortunately, these methods are merely limited to clinical settings, and symptom-based methods are shown to be ineffective. In contrast, vital signs (e.g., heart rate) have been utilized to early-detect different respiratory diseases in ubiquitous health monitoring. We posit that such biomarkers are informative in identifying ARDS patients infected with COVID-19. In this study, we investigate the behavior of COVID-19 on ARDS patients by utilizing simple vital signs. We analyze the long-term daily logs of blood pressure and heart rate associated with 70 ARDS patients admitted to five University of California academic health centers (containing 42506 samples for each vital sign) to distinguish subjects with COVID-19 positive and negative test results. In addition to the statistical analysis, we develop a deep neural network model to extract features from the longitudinal data. Using only the first eight days of the data, our deep learning model is able to achieve 78.79% accuracy to classify the vital signs of ARDS patients infected with COVID-19 versus other ARDS diagnosed patients.
翻译:在本次研究进行之时,美国受感染的人数是全球最高的(790万)。在受感染人口中,经诊断患有急性呼吸困难综合症(ARDS)的病人处于更威胁生命的状态,导致呼吸系统严重故障。各种研究通过监测实验室的测量和症状,对COVID-19和ARDS的感染情况进行了调查。不幸的是,这些方法仅限于临床环境,以症状为基础的方法证明无效。相比之下,在无处不在的健康监测中,美国感染者的人数(例如心脏病率)被早期发现不同的呼吸道疾病。在受感染人口中,经诊断患有急性呼吸困难综合症(ARDS)的病人处于更威胁生命的环境中,导致严重呼吸系统衰竭。在这项研究中,我们通过监测实验室的测量指标和症状,对COVIDS-19病人的感染情况进行了调查。我们分析了与加利福尼亚大学五所接纳的70名ARDS病人有关的血液压力和心率长期日记录(包括每个重要标志的4 006个样本),从而将具有CVIDS的18-19个核心数据样本与我们所测得的18天的统计结果。我们仅能的18DS的统计结果。我们用8DSDS的18DS网络进行长期数据分析。